Qualcomm is Building a Digital Human Brain

February 14, 2012 | by

During the President’s Lecture Series at San Diego State University two weeks ago, Qualcomm CEO Paul Jacobs said that the company is building a digital human brain. Stating that the brain isn’t programmed but rather taught, Jacobs emphasized that the company’s work was meant to help humanity through the “digital sixth sense” — the merging of the cyber and real worlds.

He described the process of discovery this way:

The team actually started out by building a retina and they came to me and said: ‘Look, it responds to these optical illusions the same way a human does.’ They put another layer of cells behind that [and] it started to find features. They put another layer, it started to find corners or oriented lines or something. Another layer, it started to find patterns.

Jacobs is talking about Brain Corporation, a small research company that is developing novel algorithms based on the functionality of the nervous system, with applications in visual perception, motor control, and autonomous navigation. The intention is to equip consumer devices, such as mobile phones or household robots, with artificial nervous systems. Qualcomm funds Brain Corporation research and hosts the company on its campus in San Diego, California.

Scientists at Brain Corporation are re-creating in the computer the shapes of every one of the billions of nerve cells that make up our brains, the component parts of intricate neural circuits that allow us to move, see and hear, to feel and to think. With this new tool, researchers are beginning to decipher the secrets of the brain’s architecture, which may one day enable us to build smart technologies that surpass the capabilities of anything we have today.

This video is based on a paper published by neuroscientist Hermann Cuntz, and colleagues in the online journal PLoS Computational Biology.

Study: One Rule to Grow Them All: A General Theory of Neuronal Branching and Its Practical Application

Source: KPBS.org

Study Suggests that Alzheimer’s Disease Spreads Through the Brain

February 13, 2012 | by

Scientists have long debated whether Alzheimer’s disease starts in separate regions of the brain independently and at different times, or if it begins in one region and then spreads. Data from researchers at Columbia University Medical Center supports the latter model, showing that abnormal tau protein — a key feature observed in the brains of patients with Alzheimer’s disease — propagates along anatomically connected networks, between connected and vulnerable neurons. The study was published earlier this month in the online journal PLoS ONE [1].

Neural network in human brainImage credit: Neurons network in human brain via Shutterstock

Memories are Made of This: Differences in Working Memory with Age are Linked to Memory Strategies Used

January 23, 2012 | by

It seems to be a fact of life that memory performance decreases as we age, but new research helps to understand what precisely is decreasing, why and points towards strategies that might help. A study published in the journal Memory suggests that older adults perform less well on working memory tasks as they do not forget information that is no longer relevant [1]. This might sound like a good thing, but it leads to overload of memory processes, damaging memory performance.

Images in the mindImages in the mind image via Shutterstock

Schizophrenia and Epilepsy May be Linked, Shared Cause Not Yet Known

September 28, 2011 | by

A recent study published in the journal Epilepsia indicates that there is a bidirectional relationship between schizophrenia and epilepsy [1]. This means that people with schizophrenia are at a higher risk of developing epilepsy, and those with epilepsy face a higher risk of developing schizophrenia. The fact that each disorder acts as a risk factor for the other indicates that the two may share some underlying causative factors, be they genetic, environmental, or neurological in origin.

Schizophrenia and epilepsy

Brain Stent Fails to Prevent Strokes, NIH Stroke Prevention Trial has Immediate Implications for Clinical Practice

September 19, 2011 | by

Patients at a high risk for a second stroke who received intensive medical treatment had fewer strokes and deaths than patients who received a brain stent in addition to the medical treatment, a large nationwide clinical trial has shown. The investigators published the results in the online first edition of the New England Journal of Medicine [1]. The National Institute of Neurological Disorders and Stroke (NINDS), part of the National Institutes of Health, funded the trial. The medical regimen included daily blood-thinning medications and aggressive control of blood pressure and cholesterol.

New enrollment in the study was stopped in April because early data showed significantly more strokes and deaths occurred among the stented patients at the 30-day mark compared to the group who received the medical management alone.

Stent